Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
M. D. Perloff, L. L. Von Moltke & D. J. Greenblatt. (2004) Ritonavir and dexamethasone induce expression of CYP3A and P-glycoprotein in rats. Xenobiotica 34:2, pages 133-150.
Read now
Read now
Articles from other publishers (22)
Dwayne Koot & Duncan Cromarty. (2015) Anticancer efficacy and toxicokinetics of a novel paclitaxel-clofazimine nanoparticulate co-formulation. Drug Delivery and Translational Research 5:3, pages 257-267.
Crossref
Crossref
Mohamed Saeed, Maen Zeino, Onat Kadioglu, Manfred Volm & Thomas Efferth. (2014) Overcoming of P-glycoprotein-mediated multidrug resistance of tumors in vivo by drug combinations. Synergy 1:1, pages 44-58.
Crossref
Crossref
Tim Moons, Mariska de Roo, Stephan Claes & Geert Dom. (2011) Relationship between P-glycoprotein and second-generation antipsychotics. Pharmacogenomics 12:8, pages 1193-1211.
Crossref
Crossref
Mark Jean Gnoth, Ulf Buetehorn, Uwe Muenster, Thomas Schwarz & Steffen Sandmann. (2011) In Vitro and In Vivo P-Glycoprotein Transport Characteristics of Rivaroxaban. Journal of Pharmacology and Experimental Therapeutics 338:1, pages 372-380.
Crossref
Crossref
Susan J. Zunino, David H. Storms & Jonathan M. Ducore. (2010) Novel in vivo model of inducible multi-drug resistance in acute lymphoblastic leukemia with chromosomal translocation t(4;11). Cancer Letters 296:1, pages 49-54.
Crossref
Crossref
Tatiana Bogush & Jacques Robert. 2009. ABC Transporters and Multidrug Resistance. ABC Transporters and Multidrug Resistance
349
362
.
Eva M. del Amo, Aki T. Heikkinen & Jukka M?nkk?nen. (2009) In vitro?in vivo correlation in p-glycoprotein mediated transport in intestinal absorption. European Journal of Pharmaceutical Sciences 36:2-3, pages 200-211.
Crossref
Crossref
Christoph K. Thoeringer, Thomas Wultsch, Anaid Shahbazian, Evelin Painsipp & Peter Holzer. (2007) Multidrug-resistance gene 1-type p-glycoprotein (MDR1 p-gp) inhibition by tariquidar impacts on neuroendocrine and behavioral processing of stress. Psychoneuroendocrinology 32:8-10, pages 1028-1040.
Crossref
Crossref
Luciana C. Borowski, Rodrigo P. Lopes, Tatiana P. Gonzalez, Luana A. Dummer, José Artur B. Chies, Inês G. Silveira, Mauro Keisermann & Moisés E. Bauer. (2007) Is steroid resistance related to multidrug resistance-I (MDR-I) in rheumatoid arthritis?. International Immunopharmacology 7:6, pages 836-844.
Crossref
Crossref
Sarah Findling-Kagan, Hamutal Sivan, Olga Ostrovsky, Arnon Nagler & Hanan Galski. (2005) Establishment and characterization of new cellular lymphoma model expressing transgenic human MDR1. Leukemia Research 29:4, pages 407-414.
Crossref
Crossref
Manfred UhrChristian Namendorf, Markus T. Grauer, Markus Rosenhagen & Martin Ebinger. (2016) P-glycoprotein is a factor in the uptake of dextromethorphan, but not of melperone, into the mouse brain: evidence for an overlap in substrate specificity between P-gp and CYP2D6. Journal of Psychopharmacology 18:4, pages 509-515.
Crossref
Crossref
Mike Franklin, Alison Reed & Harald Murck. (2004) Sub-chronic treatment with an extract of Hypericum perforatum (St John’s wort) significantly reduces cortisol and corticosterone in the rat brain. European Neuropsychopharmacology 14:1, pages 7-10.
Crossref
Crossref
Marianne B Müller, Martin E Keck, Elisabeth B Binder, Adelheid E Kresse, Thomas P Hagemeyer, Rainer Landgraf, Florian Holsboer & Manfred Uhr. (2003) ABCB1 (MDR1)-Type P-Glycoproteins at the Blood–Brain Barrier Modulate the Activity of the Hypothalamic–Pituitary–Adrenocortical System: Implications for Affective Disorder. Neuropsychopharmacology 28:11, pages 1991-1999.
Crossref
Crossref
Manfred Uhr, Markus T Grauer & Florian Holsboer. (2003) Differential enhancement of antidepressant penetration into the brain in mice with abcb1ab (mdr1ab) P-Glycoprotein gene disruption. Biological Psychiatry 54:8, pages 840-846.
Crossref
Crossref
Manfred Uhr & Markus T. Grauer. (2003) abcb1ab P-glycoprotein is involved in the uptake of citalopram and trimipramine into the brain of mice. Journal of Psychiatric Research 37:3, pages 179-185.
Crossref
Crossref
L.A Garraway & B Chabner. (2002) MDR1 inhibition: less resistance or less relevance?. European Journal of Cancer 38:18, pages 2337-2340.
Crossref
Crossref
Qiuwen Mi, Baoliang Cui, Gloria L Silva, Daniel Lantvit, Eula Lim, Heebyung Chai, Melinda G Hollingshead, Joseph G Mayo, A.Douglas Kinghorn & John M Pezzuto. (2002) Pervilleines B and C, new tropane alkaloid aromatic esters that reverse the multidrug-resistance in the hollow fiber assay. Cancer Letters 184:1, pages 13-20.
Crossref
Crossref
Andrew Crowe. (2002) The influence of P-glycoprotein on morphine transport in Caco-2 cells. Comparison with paclitaxel. European Journal of Pharmacology 440:1, pages 7-16.
Crossref
Crossref
Terry R Stouch & Olafur Gudmundsson. (2002) Progress in understanding the structure?activity relationships of P-glycoprotein. Advanced Drug Delivery Reviews 54:3, pages 315-328.
Crossref
Crossref
Matthew Troutman, Gang Luo, Liang-Shang Gan & Dhiren Thakker. 2001. Drug-Drug Interactions. Drug-Drug Interactions
295
357
.
A. M. Karssen, O. C. Meijer, I. C. J. van der Sandt, P. J. Lucassen, E. C. M. de Lange, A. G. de Boer & E. R. de Kloet. (2001) Multidrug Resistance P-Glycoprotein Hampers the Access of Cortisol But Not of Corticosterone to Mouse and Human Brain. Endocrinology 142:6, pages 2686-2694.
Crossref
Crossref
Jose Prados, Consolación Melguizo, Juan Antonio Marchal, Celia Vélez, Luis Alvarez & Antonia Aránega. (2005) Multidrug Resistance Phenotype in the RMS‐GR Human Rhabdomyosarcoma Cell Line Obtained after Polychemotherapy. Japanese Journal of Cancer Research 90:7, pages 788-793.
Crossref
Crossref